Table 1.

Summary of cases described in text and/or shown in figures

Case	Physiology	IO labeling				Anatomical zone	Zebrin	LRn labeling			Pn labeling			Ratio Pn/LRn
		MAO	vfDAO	PO	Total			Ipsilateral	Contralateral	Total	Ipsilateral	Contralateral	Total
GR03	No	0	167	0	167	C1-COP	P4−(e)	358	100	458	20	778	798	1.74
979	No	8	77	4	89	C1-PMD	P5a−	241	70	311	115	594	709	2.28
AP03a	FL-ip	0	104	1	105	C1-PMD	P5a−	181	53	234	82	550	632	2.70
AP10	FL-ip	0	73	0	73	C1-PMD	P5a−	96	18	114	33	355	388	3.40
981	No	23	1	0	24	C2-COP	P5+/7+	59	14	73	17	259	276	3.78
AP09	FL-ip, FL-co	37	3	0	40	C2-PMD	P5+	103	32	135	39	573	612	4.53
864	No	93	4	0	97	C2-PMD	P5+	63	26	89	58	432	490	5.51
A41	Face-ip	29	0	0	29	C2-Crus2B	P5+	36	17	53	52	337	389	7.34
978	No	5	0	12	17	D0/D1-PMD	P6+/7+	37	10	47	13	446	459	9.77
AP02a	FL-ip	0	6	53	59	D0/D1-PMD	P6+/7+	53	18	71	42	1051	1093	15.39
980	No	0	0	20	20	D1-PMD	P6+/7+	19	9	28	20	427	447	15.96

Cell counts were performed in a one of four series of sections in all cases. co, Contralateral; FL, forelimb; IO, inferior olive; ip, ipsilateral.

^aExperiments were performed in Bristol, United Kingdom; all other experiments were conducted in Rotterdam, The Netherlands.